228 related articles for article (PubMed ID: 34777329)
1. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.
Sánchez-Maldonado JM; Cáliz R; López-Nevot MÁ; Cabrera-Serrano AJ; Moñiz-Díez A; Canhão H; Ter Horst R; Quartuccio L; Sorensen SB; Glintborg B; Hetland ML; Filipescu I; Pérez-Pampin E; Conesa-Zamora P; Swierkot J; den Broeder AA; De Vita S; Petersen ERB; Li Y; Ferrer MA; Escudero A; Netea MG; Coenen MJH; Andersen V; Fonseca JE; Jurado M; Bogunia-Kubik K; Collantes E; Sainz J
Front Immunol; 2021; 12():672255. PubMed ID: 34777329
[TBL] [Abstract][Full Text] [Related]
2. NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium.
Manuel Sánchez-Maldonado J; Martínez-Bueno M; Canhão H; Ter Horst R; Muñoz-Peña S; Moñiz-Díez A; Rodríguez-Ramos A; Escudero A; Sorensen SB; Hetland ML; Ferrer MA; Glintborg B; Filipescu I; Pérez-Pampin E; Conesa-Zamora P; García A; den Broeder A; De Vita S; Hove Jacobsen SE; Collantes E; Quartuccio L; Netea MG; Li Y; Fonseca JE; Jurado M; López-Nevot MÁ; Coenen MJH; Andersen V; Cáliz R; Sainz J
Sci Rep; 2020 Mar; 10(1):4316. PubMed ID: 32152480
[TBL] [Abstract][Full Text] [Related]
3. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.
Márquez A; Ferreiro-Iglesias A; Dávila-Fajardo CL; Montes A; Pascual-Salcedo D; Perez-Pampin E; Moreno-Ramos MJ; García-Portales R; Navarro F; Moreira V; Magro C; Caliz R; Ferrer MA; Alegre-Sancho JJ; Joven B; Carreira P; Balsa A; Vasilopoulos Y; Sarafidou T; Cabeza-Barrera J; Narvaez J; Raya E; Cañete JD; Fernández-Nebro A; Ordóñez Mdel C; de la Serna AR; Magallares B; Gomez-Reino JJ; González A; Martín J
Arthritis Res Ther; 2014 Mar; 16(2):R66. PubMed ID: 24612463
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis.
Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NH; Andersen V
PLoS One; 2015; 10(10):e0139781. PubMed ID: 26440629
[TBL] [Abstract][Full Text] [Related]
5. Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis.
Umićević Mirkov M; Janss L; Vermeulen SH; van de Laar MA; van Riel PL; Guchelaar HJ; Brunner HG; Albers CA; Coenen MJ
Ann Rheum Dis; 2015 Dec; 74(12):2183-7. PubMed ID: 25114059
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
Ferreiro-Iglesias A; Montes A; Perez-Pampin E; Cañete JD; Raya E; Magro-Checa C; Vasilopoulos Y; Caliz R; Ferrer MA; Joven B; Carreira P; Balsa A; Pascual-Salcedo D; Blanco FJ; Moreno-Ramos MJ; Manrique-Arija S; Ordoñez MDC; Alegre-Sancho JJ; Narvaez J; Navarro-Sarabia F; Moreira V; Valor L; Garcia-Portales R; Marquez A; Gomez-Reino JJ; Martin J; Gonzalez A
PLoS One; 2019; 14(2):e0213073. PubMed ID: 30818333
[TBL] [Abstract][Full Text] [Related]
7. Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for
Spiliopoulou A; Colombo M; Plant D; Nair N; Cui J; Coenen MJ; Ikari K; Yamanaka H; Saevarsdottir S; Padyukov L; Bridges SL; Kimberly RP; Okada Y; van Riel PLC; Wolbink G; van der Horst-Bruinsma IE; de Vries N; Tak PP; Ohmura K; Canhão H; Guchelaar HJ; Huizinga TW; Criswell LA; Raychaudhuri S; Weinblatt ME; Wilson AG; Mariette X; Isaacs JD; Morgan AW; Pitzalis C; Barton A; McKeigue P
Ann Rheum Dis; 2019 Aug; 78(8):1055-1061. PubMed ID: 31036624
[TBL] [Abstract][Full Text] [Related]
8. Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.
Nakayama Y; Watanabe R; Murakami K; Murata K; Tanaka M; Ito H; Yamamoto W; Ebina K; Hata K; Hiramatsu Y; Katayama M; Son Y; Amuro H; Akashi K; Onishi A; Hara R; Yamamoto K; Ohmura K; Matsuda S; Morinobu A; Hashimoto M
Rheumatol Int; 2022 Jul; 42(7):1227-1234. PubMed ID: 35266034
[TBL] [Abstract][Full Text] [Related]
9. Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.
Luque-Tévar M; Perez-Sanchez C; Patiño-Trives AM; Barbarroja N; Arias de la Rosa I; Abalos-Aguilera MC; Marin-Sanz JA; Ruiz-Vilchez D; Ortega-Castro R; Font P; Lopez-Medina C; Romero-Gomez M; Rodriguez-Escalera C; Perez-Venegas J; Ruiz-Montesinos MD; Dominguez C; Romero-Barco C; Fernandez-Nebro A; Mena-Vazquez N; Marenco JL; Uceda-Montañez J; Toledo-Coello MD; Aguirre MA; Escudero-Contreras A; Collantes-Estevez E; Lopez-Pedrera C
Front Immunol; 2021; 12():631662. PubMed ID: 33833756
[No Abstract] [Full Text] [Related]
10. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.
Umiċeviċ Mirkov M; Cui J; Vermeulen SH; Stahl EA; Toonen EJ; Makkinje RR; Lee AT; Huizinga TW; Allaart R; Barton A; Mariette X; Miceli CR; Criswell LA; Tak PP; de Vries N; Saevarsdottir S; Padyukov L; Bridges SL; van Schaardenburg DJ; Jansen TL; Dutmer EA; van de Laar MA; Barrera P; Radstake TR; van Riel PL; Scheffer H; Franke B; Brunner HG; Plenge RM; Gregersen PK; Guchelaar HJ; Coenen MJ
Ann Rheum Dis; 2013 Aug; 72(8):1375-81. PubMed ID: 23233654
[TBL] [Abstract][Full Text] [Related]
11. Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.
Ogawa Y; Takahashi N; Kaneko A; Hirano Y; Kanayama Y; Yabe Y; Oguchi T; Fujibayashi T; Takagi H; Hanabayashi M; Funahashi K; Hayashi M; Tsuboi S; Asai S; Asai N; Matsumoto T; Sobue Y; Ishiguro N; Kojima T
Clin Rheumatol; 2019 Oct; 38(10):2757-2763. PubMed ID: 31179526
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.
Honne K; Hallgrímsdóttir I; Wu C; Sebro R; Jewell NP; Sakurai T; Iwamoto M; Minota S; Jawaheer D
Arthritis Res Ther; 2016 Jan; 18():12. PubMed ID: 26776603
[TBL] [Abstract][Full Text] [Related]
13.
Iwaszko M; Wielińska J; Świerkot J; Kolossa K; Sokolik R; Bugaj B; Chaszczewska-Markowska M; Jeka S; Bogunia-Kubik K
Front Immunol; 2021; 12():631603. PubMed ID: 34177886
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
Canet LM; Sánchez-Maldonado JM; Cáliz R; Rodríguez-Ramos A; Lupiañez CB; Canhão H; Martínez-Bueno M; Escudero A; Segura-Catena J; Sorensen SB; Hetland ML; Soto-Pino MJ; Ferrer MA; García A; Glintborg B; Filipescu I; Pérez-Pampin E; González-Utrilla A; Nevot MÁL; Conesa-Zamora P; Broeder AD; De Vita S; Jacobsen SEH; Collantes-Estevez E; Quartuccio L; Canzian F; Fonseca JE; Coenen MJH; Andersen V; Sainz J
Pharmacogenomics J; 2019 Feb; 19(1):83-96. PubMed ID: 30287909
[TBL] [Abstract][Full Text] [Related]
15. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
Tan RJ; Gibbons LJ; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
Ann Rheum Dis; 2010 Jun; 69(6):1029-35. PubMed ID: 20444755
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.
Canet LM; Filipescu I; Cáliz R; Lupiañez CB; Canhão H; Escudero A; Segura-Catena J; Soto-Pino MJ; Ferrer MA; García A; Romani L; Pérez-Pampin E; González-Utrilla A; López Nevot MA; Collantes E; Fonseca JE; Sainz J
Pharmacogenet Genomics; 2015 Jul; 25(7):323-33. PubMed ID: 25850964
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.
Plant D; Bowes J; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; ; Barton A
Arthritis Rheum; 2011 Mar; 63(3):645-53. PubMed ID: 21061259
[TBL] [Abstract][Full Text] [Related]
18. CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients.
Ammitzbøll CG; Steffensen R; Bøgsted M; Hørslev-Petersen K; Hetland ML; Junker P; Johansen JS; Pødenphant J; Østergaard M; Ellingsen T; Stengaard-Pedersen K
Arthritis Res Ther; 2014 Oct; 16(5):475. PubMed ID: 25359432
[TBL] [Abstract][Full Text] [Related]
19. Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis.
Lopez-Rodriguez R; Perez-Pampin E; Marquez A; Blanco FJ; Joven B; Carreira P; Ferrer MA; Caliz R; Valor L; Narvaez J; Cañete JD; Ordoñez MDC; Manrique-Arija S; Vasilopoulos Y; Balsa A; Pascual-Salcedo D; Moreno-Ramos MJ; Alegre-Sancho JJ; Navarro-Sarabia F; Moreira V; Garcia-Portales R; Raya E; Magro-Checa C; Martin J; Gomez-Reino JJ; Gonzalez A
PLoS One; 2018; 13(5):e0196793. PubMed ID: 29734345
[TBL] [Abstract][Full Text] [Related]
20. Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.
Julià A; Blanco F; Fernández-Gutierrez B; González A; Cañete JD; Maymó J; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González-Álvaro I; Fernandez-Nebro A; Erra A; Sánchez-Fernández S; Alonso A; López-Lasanta M; Tortosa R; Codó L; Lluis Gelpi J; García-Montero AC; Bertranpetit J; Absher D; Myers RM; Tornero J; Marsal S
Arthritis Rheumatol; 2016 Jun; 68(6):1384-91. PubMed ID: 26815016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
